Talk:Lavoltidine
Page contents not supported in other languages.
From Wikipedia, the free encyclopedia
Latest comment: 10 years ago by Ged UK in topic Requested move 12 January 2016
This is the talk page for discussing improvements to the Lavoltidine article.
This is not a forum for general discussion of the subject of the article.
This is not a forum for general discussion of the subject of the article.
- Add new text under old text.
- New to Wikipedia? Welcome! Learn to edit; get help.
- Assume good faith
- Be polite and avoid personal attacks
- Be welcoming to newcomers
- Seek dispute resolution if needed
Article policies
This article is rated Stub-class on Wikipedia's content assessment scale.
It is of interest to the following WikiProjects:
It is of interest to the following WikiProjects:
WikiProject icon This article is within the scope of WikiProject Pharmacology , a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology
Low This article has been rated as Low-importance on the project's importance scale.
WikiProject icon This article is within the scope of WikiProject Chemicals , a daughter project of WikiProject Chemistry , which aims to improve Wikipedia's coverage of chemicals . To participate, help improve this article or visit the project page for details on the project.ChemicalsWikipedia:WikiProject ChemicalsTemplate:WikiProject Chemicalschemicals
Low This article has been rated as Low-importance on the project's importance scale.
Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Lavoltidine.
- PubMed provides review articles from the past five years (limit to free review articles )
- The TRIP database provides clinical publications about evidence-based medicine .
- Other potential sources include: Centre for Reviews and Dissemination and CDC
- The following is a closed discussion of a requested move. Please do not modify it. Subsequent comments should be made in a new section on the talk page. Editors desiring to contest the closing decision should consider a move review. No further edits should be made to this section.
The result of the move request was: page moved via speedy request. Ged UK 12:40, 14 January 2016 (UTC) Reply
Loxtidine → Lavoltidine – Lavoltidine is an established International Nonproprietary Name of loxtidine. Source: [1] vaccinationist (talk|edits) 14:26, 12 January 2016 (UTC) Reply
References
- ↑ "WHO Drug Information. Vol 4, No. 3, 1990. International Nonproprietary Names for Pharmaceutical Substances. Recommended International Nonproprietary Names (Rec. INN): List 30" (PDF). World Health Organization. p. 7. Retrieved 12 January 2016.
- The above discussion is preserved as an archive of a requested move. Please do not modify it. Subsequent comments should be made in a new section on this talk page or in a move review. No further edits should be made to this section.